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Abstract
The aim of the present study was to determine the effect of the oral
ingestion of an extract of the herb Uncaria tomentosa (cat’s claw) on
the biodistribution of the radiobiocomplex sodium pertechnetate
(Na99mTcO4) in rats. The animals (male Wistar rats, 2 months old, 180-
220 g), were treated (1 mL) with an U. tomentosa extract (32 mg/mL,
N = 5) or 0.9% NaCl solution (control, N = 5) for 7 days. After this
period, Na99mTcO4 (3.7 MBq, 0.3 mL) was injected through the ocular
plexus and after 10 min the rats were killed, the organs isolated and
counted in a well-gamma counter. A significant (P < 0.05) alteration
in Na99mTcO4 uptake i) from 0.57 ± 0.008 to 0.39 ± 0.06 %ATI/organ
(P < 0.05) and from 0.57 ± 0.17 to 0.39 ± 0.14 %ATI/g (P < 0.05) was
observed in the heart, ii) from 0.07 ± 0.02 to 0.19 ± 0.07 %ATI/g in the
pancreas, and iii) from 0.07 ± 0.01 to 0.18 ± 0.07 %ATI/g (P < 0.05)
in muscle after treatment with this extract. Although these results were
obtained with animals, caution is advisable in the interpretation of the
nuclear medicine examination when the patient is using this herb. This
finding is probably an example of drug interaction with a radiophar-
maceutical, a fact that could lead to misdiagnosis of the examination
in clinical practice with unexpected consequences for the patient.
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Uncaria tomentosa (cat’s claw) is a me-
dicinal herb that has been used by the indig-
enous people of Peru for over 2000 years.
Explorers of the 1800’s noticed healthy, ro-
bust natives who seemed to be disease and
cancer free. They took note of a tea the natives
were constantly drinking which was obtained
from the bark of this woody vine (1).
U. tomentosa was brought to Europe and
in the 1990’s it became a complementary
treatment for AIDS and cancer (1,2). It is a
potent plant with 29 described chemical con-
stituents including 17 different alkaloids with
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cytoprotective, and immunomodulating (2,3).
Despite the beneficial effects reported by
users, the indiscriminate use of this and other
plants and infusions without medical advice/
criteria can be dangerous (4,5). Several cases
of toxic effects of medicinal plants have
been reported; however, the toxicity, drug
interaction and side effects of these products
are not completely known (4,5).
Radiopharmaceuticals (radiobiocom-
plexes) (6) are radioactive tracers employed
in nuclear medicine for the study of several
morphological and physiological conditions,
such as blood flow and absorption, biodistri-
bution, and metabolism in target and non-
target organs (7).
Many natural and synthetic products have
been reported to affect the biodistribution of
different radiobiocomplexes (6-9). The in-
corporation of a radionuclide into a drug
formulation permits the determination of the
biodistribution kinetics and the release sites
of the latter (10,11). Technetium-99m (Tc-
99m) has been widely used in nuclear medi-
cine due to its optimal half-life (6.0 h) and
energy characteristics, providing images with
high efficiency with the administration of
low doses to the patient (10,11). Radiobio-
complexes such as sodium pertechnetate
(Na99mTcO4) are tracers widely employed in
scintigraphic studies (single-photon emis-
sion computed tomography - SPECT) mainly
of the thyroid but also of the brain and
stomach (10,11).
Since human beings that are using U.
tomentosa may need a nuclear medicine pro-
cedure, the aim of the present study was to
evaluate the effect of U. tomentosa on the
biodistribution of the radiobiocomplex
Na99mTcO4 in an experimental model using
Wistar rats.
Aqueous preparations of a commercial
U. tomentosa extract (Cats Claw, Herbarium
Foundation for Health and Research, Curiti-
ba, PR, Brazil, Lot No. 830283) were ob-
tained using 0.9% NaCl. To obtain the prepa-
ration considered to be 100%, 320 mg lyo-
philized leaves (dried) of Uncaria was placed
in a vial with 10 mL saline solution (0.9%
NaCl) at room temperature. This preparation
was centrifuged in a clinical centrifuge (1500
rpm, 5 min) and the supernatant, 32 mg/mL,
was considered to be 100%.
Two-month-old male Wistar rats (180-
220 g) were obtained from Laboratório de
Radiofarmácia Experimental (Departamento
de Biofísica e Biometria, Universidade do
Estado do Rio de Janeiro, Rio de Janeiro, RJ,
Brazil) and maintained in a room under con-
trolled conditions (22 ± 5ºC, 12-h light/dark
cycle), with free access to water and a nor-
mal diet. Experiments were conducted in
accordance with the Department Committee
of Animal Care and with the institutional
guidelines, in compliance with national laws
and Guidelines for the Use of Animals in
Biomedical Research (12).
The U. tomentosa preparation (32 mg/mL)
was administered (1 mL) to the animals (N =
5) by gavage for 7 days. The control group
Table 1. Effect of an orally administered aqueous extract of Uncaria tomentosa on the
biodistribution of the Na99mTcO4 radiobiocomplex reported as %ATI/organ and
%ATI/g of tissue.
Organ %ATI/organ %ATI/g tissue
Control Treated Control Treated
Brain 0.13 ± 0.07 0.13 ± 0.07 0.09 ± 0.05 0.08 ± 0.03
Liver 0.26 ± 0.36 0.71 ± 0.51 2.86 ± 0.65 2.23 ± 0.47
Duodenum 0.21 ± 0.06 0.31 ± 0.12 0.61 ± 0.33 0.65 ± 0.01
Heart 0.57 ± 0.01 0.39 ± 0.06* 0.57 ± 0.17 0.39 ± 0.14*
Kidney 0.15 ± 0.16 0.14 ± 0.06 0.54 ± 0.41 0.75 ± 0.06
Spleen 0.12 ± 0.03 0.11 ± 0.07 0.71 ± 0.60 0.50 ± 0.20
Lung 0.33 ± 0.17 0.42 ± 0.10 2.07 ± 0.94 1.64 ± 0.41
Stomach 0.50 ± 0.13 0.37 ± 0.18 7.65 ± 1.16 7.70 ± 0.94
Pancreas 0.03 ± 0.01 0.08 ± 0.07 0.07 ± 0.02 0.19 ± 0.07*
Blood 1.43 ± 0.07 1.32 ± 0.11 1.43 ± 0.07 1.32 ± 0.11
Bone 0.08 ± 0.05 0.09 ± 0.05 0.30 ± 0.08 0.27 ± 0.05
Muscle 0.02 ± 0.01 0.10 ± 0.02 0.07 ± 0.01 0.18 ± 0.07*
Thyroid 0.78 ± 0.16 0.54 ± 0.21 4.97 ± 0.85 4.24 ± 2.27
Testis 0.25 ± 0.02 0.16 ± 0.14 0.26 ± 0.10 0.11 ± 0.10
Data are reported as mean ± SD for 5 animals in each group. After 7 days of treatment
with an Uncaria tomentosa extract by gavage (control, 32 mg/mL), male Wistar rats
received 0.3 mL Na99mTcO4 by the intravenous route. The animals were sacrificed, the
organs isolated and %ATI/organ and %ATI/g tissue determined.
*P < 0.05 compared to the respective control (ANOVA).
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received 0.9% NaCl (N = 5). Na99mTcO4
(0.3 mL, 3.7 MBq; Instituto de Pesquisas
Energéticas e Nucleares, Comissão Nacional
de Energia Nuclear, São Paulo, SP, Brazil)
was injected through the ocular plexus and the
animals were sacrificed 10 min later.
The organs (brain, liver, duodenum, heart,
kidney, lung, spleen, stomach, pancreas, tes-
tis, blood, bone, muscle, and thyroid) were
isolated and weighed on a clinical scale and
radioactivity was counted in a well counter
(Automatic, Gamma Counter, Packard,
Meriden, CT, USA). The percentages of ra-
dioactivity per organ (%ATI/organ) and per
gram (%ATI/g) of each organ were calcu-
lated. Data were analyzed statistically by
ANOVA followed by the t-test, with the
level of significance set at P < 0.05.
Table 1 shows the %ATI/organ of the
radiobiocomplex Na99mTcO4 in the animals
treated with U. tomentosa and in the control
group. A significant (P < 0.05) decrease in the
uptake of this radiobiocomplex from 0.57 ±
0.008 (control) to 0.39 ± 0.06 %ATI/organ
was observed in the heart (P = 0.0009). Table
1 also shows the %ATI/g tissue of Na99mTcO4
for the animals treated with U. tomentosa and
for the control group. A significant (P < 0.05)
increase in Na99mTcO4 uptake from 0.07 ±
0.02 (control) to 0.19 ± 0.07 %ATI/g in the
pancreas (P = 0.018) and from 0.07 ± 0.01
(control) to 0.18 ± 0.07 %ATI/g in muscle (P
= 0.03) was observed after treatment with the
extract. A significant (P < 0.05) decrease in the
uptake of this radiobiocomplex from 0.57 ±
0.17 (control) to 0.39 ± 0.14 %ATI/g was also
observed in the heart (P < 0.05).
The results obtained suggest that the U.
tomentosa extract can act on the biodistribu-
tion of Na99mTcO4 in specific organs. Diré et
al. (12) reported that the in vitro labeling of
blood constituents with Tc-99m (another
radiobiocomplex prepared) and the morphom-
etry of red blood cells were unchanged in rats
treated in vivo with U. tomentosa. The results
obtained by these investigators with U. tomen-
tosa in another experimental protocol and the
findings of the present study indicate that the
herb-radiobiocomplex interaction depends on
the experimental conditions employed and on
the radiobiocomplex studied.
Some studies are available about the
effects of several natural and synthetic sub-
stances on the biodistribution of the
Na99mTcO4 radiobiocomplex. Moreno et al.
(6) reported that Ginkgo biloba extract al-
tered the uptake of Na99mTcO4 in several
organs. Diré et al. (8) demonstrated that
natural products such as chayotte extracts
can also induce changes in the biodistribu-
tion of Na99mTcO4. Jankovic and Djokic (9)
reported the alteration of the organ uptake of
several radiobiocomplexes labeled with Tc-
99m induced by the administration of the
cytotoxic drugs methotrexate sodium and
cyclophosphamide using this same experi-
mental model.
When the drug interaction with radiobio-
complexes is unknown, the examination is not
recommended, since the consequences of the
procedure are the possibility of misdiagnosis
and/or repetition of the examination, with an
increase in the radiation dose administered to
the patient (7,13). When the drug interaction
with radiobiocomplexes is known, whether
desirable or undesirable, the natural conse-
quence is a correct diagnosis (7).
Since in the present study the treatment
with Uncaria decreased the uptake of
Na99mTcO4 by heart, pancreas and muscle,
these findings could be considered to be an
example of herb interaction with radiobio-
complexes. The knowledge about this phe-
nomenon represents important clinical in-
formation for the best therapeutic decision
and correct diagnosis.
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